Clinical Trials Logo
  1. Home
  2. Partial Seizures
  3. NCT00407797

Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial — PREPS MEXICO  

Partial Seizures Clinical Trial

Official title:
Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial. A Phase IV Open-Label Trial Using 150,300, 600 mg/Day Of Pregabalin

Clinical Trial Summary

The purpose of this study is to assess the clinical improvement by partial seizures reduction, safety and tolerability of subjects having partial epilepsy related to the adjunction of pregabalin BID (75 to 300mg day titration, BID) to existing standard AED (Antiepileptic drugs).

Clinical Trial Description

This study was terminated on 17 March 2009 due to delayed enrollment. The decision to terminate the trial was not based on any safety concerns, but rather on timelines and the difficulty in enrolling patients in this open label, single group study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00407797
Study type Interventional
Source Pfizer
Contact
Status Terminated
Phase Phase 4
Start date March 2007
Completion date August 2009
View Details
See also
  Status Clinical Trial Phase
Completed NCT01954121 - Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures Phase 3
Completed NCT01630057 - Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug Phase 4
Completed NCT00327717 - Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures Phase 3
Completed NCT00537238 - Pregabalin Versus Levetiracetam In Partial Seizures Phase 3
Completed NCT00141258 - Pregabalin Epilepsy Add-On Trial Phase 3
Completed NCT03340064 - A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age Phase 3
Completed NCT01136954 - A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study) Phase 3
Completed NCT04257604 - A Study of Perampanel as Add-on Therapy in Adult and Adolescent Participants With Focal Seizures
Completed NCT01392768 - Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization Phase 3
Completed NCT01063764 - An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures Phase 3
Completed NCT00102713 - A Study for Treatment of Partial Seizures in Children Phase 3
Completed NCT01262677 - Once-A-Day Pregabalin For Partial Seizures Phase 3